Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium Supplementation with Concurrent Radiotherapy for Cervical Cancer
ChiCTR2100043379Phase 2Completed
- Sponsor
- Ethics Committee of Enshi Tujia and Miao Autonomous Prefecture Central Hospital
- Start
- Jan 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cervical Cancer (CC) comparing selenium yeast with Control: placebo (2 arms). Primary endpoints: Progression-free survival, Overall survival and 2 more. Started Jan 2017; status: completed.
02
Drugs
selenium yeast
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2100043379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043379.